Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficiency) - Restricted Stock Units and Performance Restricted Stock Units - Activity (Details)

v3.24.1.1.u2
Stockholders' Equity (Deficiency) - Restricted Stock Units and Performance Restricted Stock Units - Activity (Details)
12 Months Ended
Mar. 31, 2023
$ / shares
shares
Shares  
Nonvested, balance at the beginning of the period (in shares) | shares 591,805
Granted (in shares) | shares 646,814
Vested and issued (in shares) | shares (179,471)
Forfeited (in shares) | shares (216,517)
Nonvested, balance at the end of the period (in shares) | shares 842,631
Awards expected to vest (in shares) | shares 842,631
Weighted Average Grant-Date Fair Value  
Nonvested restricted stock units outstanding at the beginning of the period (in dollars per share) | $ / shares $ 5.66
Granted (in dollars per share) | $ / shares 2.04
Vested and issued (in dollars per share) | $ / shares 5.76
Forfeited (in dollars per share) | $ / shares 4.54
Nonvested restricted stock units outstanding at the end of the period (in dollars per share) | $ / shares 3.13
Awards expected to vest (in dollars per share) | $ / shares $ 3.13